Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Current Assets: 2010-2025

Historic Current Assets for Catalyst Pharmaceuticals (CPRX) over the last 13 years, with Sep 2025 value amounting to $852.5 million.

  • Catalyst Pharmaceuticals' Current Assets rose 58.16% to $852.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $852.5 million, marking a year-over-year increase of 58.16%. This contributed to the annual value of $623.6 million for FY2024, which is 184.33% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Current Assets stood at $852.5 million for Q3 2025, which was up 12.35% from $758.7 million recorded in Q2 2025.
  • Catalyst Pharmaceuticals' 5-year Current Assets high stood at $852.5 million for Q3 2025, and its period low was $161.5 million during Q1 2021.
  • Moreover, its 3-year median value for Current Assets was $474.4 million (2024), whereas its average is $471.8 million.
  • Its Current Assets has fluctuated over the past 5 years, first slumped by 31.63% in 2023, then surged by 184.33% in 2024.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Current Assets stood at $210.1 million in 2021, then soared by 52.69% to $320.8 million in 2022, then tumbled by 31.63% to $219.3 million in 2023, then skyrocketed by 184.33% to $623.6 million in 2024, then spiked by 58.16% to $852.5 million in 2025.
  • Its Current Assets stands at $852.5 million for Q3 2025, versus $758.7 million for Q2 2025 and $685.7 million for Q1 2025.